Published

194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Biological Psychiatry
Date: 2025-04-09
Source: OpenAlex
DOI: 10.1016/j.biopsych.2025.02.431
PubMed: Unavailable

Authors

Orly Lipsitz Joshua D. Rosenblat

Watch author

Derived topics and classifications

psilocybin Depression Randomized Controlled Trial Treatment-Resistant Depression Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy2025-04-09

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formationJournal of Labelled Compounds and Radiopharmaceuticals · 1998-07-01 Synthesis of psilocin labelled with 14C and 3HJournal of Labelled Compounds and Radiopharmaceuticals · 1986-02-01 Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-07-01